Vallon Pharmaceuticals Inc Forecast, price target & analysts
$7.95
0.49%
today
Nasdaq,
Feb 28, 07:41 pm CET
Vallon Pharmaceuticals Inc Target price 2025 - Analyst rating & recommendation
Powered by
Vallon Pharmaceuticals Inc Classifications & Recommendation:
Buy
100%
Vallon Pharmaceuticals Inc Price Target
| Target Price | $195.50 |
| Price | $7.99 |
| Potential |
2,346.81%
register free of charge
|
| Number of Estimates | 2 |
|
2 Analysts have issued a price target Vallon Pharmaceuticals Inc 2026 .
The average Vallon Pharmaceuticals Inc target price is $195.50.
This is
2,346.81%
register free of charge
$221.00
2,665.96%
register free of charge
$170.00
2,027.66%
register free of charge
|
|
| A rating was issued by 2 analysts: 2 Analysts recommend Vallon Pharmaceuticals Inc to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Vallon Pharmaceuticals Inc stock has an average upside potential 2026 of
2,346.81%
register free of charge
|
Current Vallon Pharmaceuticals Inc Upgrades & Downgrades Beta
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. | Locked ➜ Locked | Locked | Dec 09 2024 |
| Ascendiant Capital | Locked ➜ Locked | Locked | Dec 05 2024 |
| Ascendiant Capital | Locked ➜ Locked | Locked | Oct 08 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Dec 09 2024 |
|
Locked
Ascendiant Capital: Locked ➜ Locked
|
Dec 05 2024 |
|
Locked
Ascendiant Capital: Locked ➜ Locked
|
Oct 08 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
